Valuation Picture: Premium but Close to Industry Norms
The current P/E of 63.85 for Apollo Hospitals Enterprise Ltd. sits just above the hospital sector’s average of 62.99, indicating a valuation premium of approximately 1.4%. This suggests that investors are willing to pay slightly more for the stock relative to its peers, potentially reflecting confidence in its earnings growth or market positioning. However, the premium is modest, implying that the stock is not excessively overvalued compared to the sector. This valuation context is important when analysing the stock’s recent performance and technical indicators — previously rated Hold, what is Apollo Hospitals’ current rating? The four-parameter analysis factors in this valuation premium alongside other metrics.
Performance Across Timeframes: Strong Long-Term Gains with Short-Term Fluctuations
Examining returns across multiple periods reveals a stock that has delivered robust long-term gains. Over three years, Apollo Hospitals has surged 81.70%, significantly outperforming the Sensex’s 22.64% rise. The five-year return is even more striking at 148.56%, compared to the Sensex’s 49.80%, while the ten-year performance stands at an impressive 507.22%, dwarfing the Sensex’s 199.22% gain. These figures underscore the company’s sustained growth trajectory over the past decade.
However, the short-term momentum is more mixed. The stock’s one-month return of 4.22% outperforms the Sensex’s 4.50% decline, and the three-month return of 6.04% contrasts with the Sensex’s 8.58% fall, signalling resilience in recent months. Yet, the one-week performance shows a slight dip of 0.55%, while the one-day change is a marginal decline of 0.34%, both underperforming the Sensex’s positive moves in these periods. This divergence between short-term softness and longer-term strength raises questions about the stock’s immediate momentum — is this a temporary pause or a sign of shifting investor sentiment?
Moving Average Configuration: Bullish Across All Key Averages
Technically, Apollo Hospitals is trading above all major moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This comprehensive positioning indicates a strong upward trend and suggests that recent price action is supported by positive momentum across both short and long-term horizons. The stock’s proximity to its 52-week high, just 0.61% away from Rs 8,249.95, further reinforces this bullish technical stance.
Moreover, the stock has recorded three consecutive days of gains, accumulating a 2.23% rise during this period. This short-term strength within a broader uptrend may signal continued investor confidence, although the slight underperformance relative to the Sensex in the last week tempers this optimism somewhat — is this a genuine recovery or a relief rally that will fade at the 50 DMA?
Our latest monthly pick, this Large Cap from Aluminium & Aluminium Products, is outperforming the market! See the analysis that helped our Investment Committee select this winner.
- - Market-beating performance
- - Committee-backed winner
- - Aluminium & Aluminium Products standout
Sector Performance Context: Hospital Industry Shows Mixed Results
The hospital sector, within which Apollo Hospitals operates, has experienced a varied performance landscape recently. While some companies in the sector have posted positive returns, others have remained flat or declined, reflecting a mixed environment. The sector’s average P/E of 62.99 suggests investors are pricing in steady growth but remain cautious about near-term uncertainties. Against this backdrop, Apollo Hospitals’s slight premium and consistent outperformance over the Sensex highlight its relative strength within the industry.
Rating Reassessment: Previously Hold, Now Updated
On 11 May 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from its previous Hold status. While the current rating is not disclosed, the reassessment reflects a comprehensive review of the company’s valuation, performance, and technical indicators. This change invites investors to consider how the updated rating aligns with the stock’s premium valuation and strong long-term returns — should investors in Apollo Hospitals hold, buy more, or reconsider?
Apollo Hospitals Enterprise Ltd. caught your attention? Explore our comprehensive research report with in-depth analysis of this large-cap Hospital stock – fundamentals, valuations, financials, and technical outlook!
- - Comprehensive research report
- - In-depth large-cap analysis
- - Valuation assessment included
Conclusion: Data Reflects a Stock Balancing Valuation and Performance
The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a slight premium to its sector, supported by strong long-term returns and a bullish technical setup. While short-term performance shows some volatility, the stock remains well-positioned above all key moving averages and close to its 52-week high. The recent rating reassessment from Hold signals a fresh evaluation of these factors, inviting investors to weigh the valuation premium against the company’s consistent growth record — what is the current rating for Apollo Hospitals Enterprise Ltd.?
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
